Keyphrases
Epitope
100%
Comparative Analysis
100%
Conserved Motif
100%
Potential Therapeutics
100%
Evolutionarily Conserved
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Extracellular Domain
36%
Breast Cancer
18%
Druggability
18%
Therapeutic Antibody
9%
Novel Epitopes
9%
Acquired Resistance
9%
Peptide Vaccine
9%
Functional Regions
9%
Tumor Aggressiveness
9%
Protein Data
9%
PROSITE
9%
Trastuzumab
9%
Computational Process
9%
HER2 mutation
9%
Pertuzumab
9%
Anti-human Epidermal Growth Factor Receptor 2
9%
X-ray Crystal Structure
9%
Poor Prognosis
9%
Overexpressing
9%
Computational Approach
9%
Clinically Significant
9%
Auxiliary Tool
9%
Drug Design
9%
Targeted Treatment
9%
Overexpression
9%
Therapeutic Use
9%
Clinical Management
9%
Immunology and Microbiology
Epitope
100%
Gamma Urogastrone
100%
Epidermal Growth Factor
100%
Therapeutic Antibodies
11%
Protein Crystal Structure
11%
Trastuzumab
11%
Pertuzumab
11%
Biochemistry, Genetics and Molecular Biology
Pertuzumab
10%
PROSITE
10%
Therapeutic Antibodies
10%